Who Supplies Lapatinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Lapatinib exports, with 86+ registered manufacturers shipping to buyers across 49+ countries — yet a handful of companies dominate the shipments. NATCO PHARMA LIMITED holds the largest share at 32.8% (export value: $1.8M). Close behind, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED (5.7%, $303.4K). MEDWISE OVERSEAS PRIVATE LIMITED (1.6%, $85.5K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Lapatinib? Top Manufacturers & Their Buyers
Flow of Lapatinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Lapatinib Supplier Network — Key Market Intelligence
The Lapatinib export market from India is led by NATCO PHARMA LIMITED, which alone commands a 32.8% share, shipping $1.8M worth of product across 22 shipments. The second-largest exporter, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, contributes $303.4K (5.7%) to the overall market. Combined, the top two suppliers alone account for 38.4% of all Lapatinib exports, indicating a relatively concentrated supply base.
Across all 86 tracked manufacturers, the total Lapatinib export value stands at $5.4M from 300 shipments. The market average shipment value is $17.8K. The single largest buyer relationship in terms of trade value is UPS, receiving $852.1K worth of product.
The combined buyer network spans 12 named purchasing companies, including UPS, UPS SUPPLY CHAIN SOL, ONE PHARMA MEDICS, EVEREST BANK LTD, EVEREST BANK LIMITED and 7 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the first-largest Lapatinib exporter from India, with a market share of 32.8% and a total export value of $1.8M across 22 shipments. Their average shipment value of $79.7K is above the market average of $17.8K, suggesting premium or bulk contract pricing.
NATCO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• UPS — $852.1K across 11 shipments (48.6% of this supplier's total exports)
• UPS SUPPLY CHAIN SOL — $840.2K across 11 shipments (47.9% of this supplier's total exports)
• ONE PHARMA MEDICS — $47.7K across 1 shipments (2.7% of this supplier's total exports)
• EVEREST BANK LTD — $10.0K across 0 shipments (0.6% of this supplier's total exports)
• EVEREST BANK LIMITED — $4.2K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED's per-shipment value of $79.7K is 347% above the market average of $17.8K, consistent with large-order contracts or value-added formulations.
2BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the second-largest Lapatinib exporter from India, with a market share of 5.7% and a total export value of $303.4K across 12 shipments. Their average shipment value of $25.3K is above the market average of $17.8K, suggesting premium or bulk contract pricing.
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AMINCORP — $119.5K across 5 shipments (39.4% of this supplier's total exports)
• TOROPH — $99.4K across 4 shipments (32.8% of this supplier's total exports)
• TOROPH — $70.1K across 3 shipments (23.1% of this supplier's total exports)
• TANEPVLT — $14.4K across 1 shipments (4.7% of this supplier's total exports)
Key Insight: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED's per-shipment value of $25.3K is 42% above the market average of $17.8K, consistent with large-order contracts or value-added formulations.
3MEDWISE OVERSEAS PRIVATE LIMITED
MEDWISE OVERSEAS PRIVATE LIMITED is the third-largest Lapatinib exporter from India, with a market share of 1.6% and a total export value of $85.5K across 3 shipments. Their average shipment value of $28.5K is above the market average of $17.8K, suggesting premium or bulk contract pricing.
MEDWISE OVERSEAS PRIVATE LIMITED serves 2 named buyers in our database. M S DROGUERIA PERU S is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• M S DROGUERIA PERU S — $85.5K across 3 shipments (100.0% of this supplier's total exports)
• NA — $0 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: MEDWISE OVERSEAS PRIVATE LIMITED's per-shipment value of $28.5K is 60% above the market average of $17.8K, consistent with large-order contracts or value-added formulations.
4IKRIS PHARMA NETWORK PRIVATE LIMITED
IKRIS PHARMA NETWORK PRIVATE LIMITED is the fourth-largest Lapatinib exporter from India, with a market share of 0.8% and a total export value of $42.9K across 3 shipments. Their average shipment value of $14.3K is below the market average of $17.8K, reflecting a high-volume, competitive pricing strategy.
IKRIS PHARMA NETWORK PRIVATE LIMITED serves 1 named buyer in our database. CENTRE NATIONAL DE L is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• CENTRE NATIONAL DE L — $42.9K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: IKRIS PHARMA NETWORK PRIVATE LIMITED operates with high shipment frequency (3 shipments) at a per-shipment value of $14.3K, indicating a broad distribution network with many smaller, regular orders.
5SHREE KRISHNA LIFECARE
SHREE KRISHNA LIFECARE is the fifth-largest Lapatinib exporter from India, with a market share of 0.5% and a total export value of $25.7K across 7 shipments. Their average shipment value of $3.7K is below the market average of $17.8K, reflecting a high-volume, competitive pricing strategy.
SHREE KRISHNA LIFECARE serves 3 named buyers in our database. THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS is the dominant customer, accounting for 96.2% of this supplier's tracked business. Top customers include:
• THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS — $24.7K across 7 shipments (96.2% of this supplier's total exports)
• TO THE ORDER OF THE — $625 across 0 shipments (2.4% of this supplier's total exports)
• THE MANAGER - BBJ CO — $364 across 0 shipments (1.4% of this supplier's total exports)
Key Insight: SHREE KRISHNA LIFECARE operates with high shipment frequency (7 shipments) at a per-shipment value of $3.7K, indicating a broad distribution network with many smaller, regular orders.
6MBA PHARMACEUTICALS PRIVATE LIMITED
MBA PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Lapatinib exporter from India, with a market share of 0.4% and a total export value of $22.6K across 6 shipments. Their average shipment value of $3.8K is below the market average of $17.8K, reflecting a high-volume, competitive pricing strategy.
MBA PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. TO is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO — $22.6K across 6 shipments (100.0% of this supplier's total exports)
Key Insight: MBA PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (6 shipments) at a per-shipment value of $3.8K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Lapatinib Flows
Once Lapatinib leaves the manufacturing plants of companies like NATCO PHARMA LIMITED and BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $5.4M. United States absorbs the largest share at 54.4% ($2.9M), followed by United Arab Emirates (30.5%) and Kazakhstan (3.2%).
In United States — the top destination — named importers include M/S. UPS.
This geographic spread reflects Lapatinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Lapatinib Go? Top Importing Countries & Their Buyers
Trade flow of Lapatinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Lapatinib imports from India, with a total trade value of $2.9M across 2 shipments — representing a 54.4% share of all Lapatinib exports. The average shipment value of $1.5M is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Lapatinib importers in United States: M/S. UPS is the largest buyer, accounting for 23.7% ($690.7K) of this market's total imports.
• M/S. UPS — $690.7K (23.7% of United States's total)
Key Insight: United States's per-shipment average of $1.5M (8065% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Lapatinib imports from India.
2United Arab Emirates
United Arab Emirates ranks as the second-largest destination for Lapatinib imports from India, with a total trade value of $1.6M across 0 shipments — representing a 30.5% share of all Lapatinib exports. The average shipment value of $1.6M is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Arab Emirates's per-shipment average of $1.6M (9051% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Lapatinib imports from India.
3Kazakhstan
Kazakhstan ranks as the third-largest destination for Lapatinib imports from India, with a total trade value of $169.5K across 5 shipments — representing a 3.2% share of all Lapatinib exports. The average shipment value of $33.9K is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Lapatinib importers in Kazakhstan: TOROPH is the largest buyer, accounting for 58.7% ($99.4K) of this market's total imports.
• TOROPH — $99.4K (58.7% of Kazakhstan's total)
• TOROPH , — $70.1K (41.3% of Kazakhstan's total)
Key Insight: Kazakhstan's per-shipment average of $33.9K (90% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kazakhstan is a key market for Lapatinib imports from India.
4Philippines
Philippines ranks as the fourth-largest destination for Lapatinib imports from India, with a total trade value of $120.7K across 5 shipments — representing a 2.3% share of all Lapatinib exports. The average shipment value of $24.1K is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Lapatinib importers in Philippines: AMINCORP is the largest buyer, accounting for 99.0% ($119.5K) of this market's total imports.
• AMINCORP — $119.5K (99.0% of Philippines's total)
Key Insight: Philippines's per-shipment average of $24.1K (35% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Lapatinib imports from India.
5Peru
Peru ranks as the fifth-largest destination for Lapatinib imports from India, with a total trade value of $85.5K across 0 shipments — representing a 1.6% share of all Lapatinib exports. The average shipment value of $85.5K is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations.
Key Insight: Peru's per-shipment average of $85.5K (379% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Peru is a key market for Lapatinib imports from India.
People Also Ask — Lapatinib Supplier & Trade Network
Who are the top suppliers of Lapatinib from India?+
Which companies buy Lapatinib from Indian manufacturers?+
Where does Lapatinib exported from India go?+
What is the market share of the top Lapatinib supplier from India?+
What is the average shipment value for Lapatinib exports from India?+
Is Lapatinib manufactured in India and exported globally?+
Which country imports the most Lapatinib from India?+
Who are the buyers of Lapatinib in United Arab Emirates?+
How concentrated is the Lapatinib supplier market in India?+
How do I find verified buyers for Lapatinib in specific countries?+
Lapatinib Trade Network — Key Takeaways
- 1NATCO PHARMA LIMITED is India's dominant Lapatinib exporter with a 32.8% market share and $1.8M in total exports — making it the single most important sourcing entity in this market.
- 2The top 86 suppliers collectively account for 41.7% of all tracked Lapatinib exports, with a combined trade value of $5.4M.
- 3United States is the largest destination market, absorbing 54.4% of India's Lapatinib exports ($2.9M). United Arab Emirates (30.5%) and Kazakhstan (3.2%) follow.
- 4With 300 total shipments averaging $17.8K each, the Lapatinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include UPS, UPS SUPPLY CHAIN SOL, AMINCORP, TOROPH — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 49 countries
Network value: $5.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lapatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lapatinib.
- 2.Flow Mapping: 86 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 300 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 49 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
300 Verified Shipments
86 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists